Dietary Regulation of Histone Acetylases and Deacetylases for the Prevention of Metabolic Diseases

被引:57
|
作者
Pham, Tho X. [1 ]
Lee, Jiyoung [1 ]
机构
[1] Univ Connecticut, Dept Nutr Sci, Storrs, CT 06269 USA
关键词
high-fat; HDAC; HAT; sulforpahane; curcumin; butyrate; epigenetics; HIGH-FAT-DIET; TRANSCRIPTION FACTOR NRF2; INSULIN-RESISTANCE; GLYCEMIC INDEX; PROINFLAMMATORY CYTOKINE; CELLULAR-METABOLISM; MATERNAL DIET; CANCER CELLS; IN-VIVO; DNA-PK;
D O I
10.3390/nu4121868
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Age-related diseases such as type 2 diabetes, cardiovascular disease, and cancer involve epigenetic modifications, where accumulation of minute changes in the epigenome over time leads to disease manifestation. Epigenetic changes are influenced by life style and diets. This represents an avenue whereby dietary components could accelerate or prevent age-related diseases through their effects on epigenetic modifications. Histone acetylation is an epigenetic modification that is regulated through the opposing action of histone acetylases (HATs) and deacetylases (HDACs). These two families of enzymes play critical roles in metabolic processes and their dysregulation is associated with pathogenesis of several diseases. Dietary components, such as butyrate, sulforaphane, and curcumin, have been shown to affect HAT and HDAC activity, and their health benefits are attributed, at least in part, to epigenetic modifications. Given the decades that it takes to accumulate epigenetic changes, it is unlikely that pharmaceuticals could undo epigenetic changes without side effects. Therefore, long term consumption of dietary components that can alter the epigenome could be an attractive means of disease prevention. The goal of this review is to highlight the roles of diets and food components in epigenetic modifications through the regulation of HATs and HDACs for disease prevention.
引用
收藏
页码:1868 / 1886
页数:19
相关论文
共 50 条
  • [31] A role for histone deacetylases in the regulation of platelet function
    Ali, M.
    Jones, C., I
    Gibbins, J. M.
    Fry, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 294 - 294
  • [32] Cytokines and pregnancy: Potential regulation by histone deacetylases
    Munro, Sheryl K.
    Balakrishnan, Biju
    Lissaman, Abbey C.
    Gujral, Palak
    Ponnampalam, Anna P.
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 2021, 88 (05) : 321 - 337
  • [33] Roles of histone acetyltransferases and deacetylases in gene regulation
    Kuo, MH
    Allis, CD
    BIOESSAYS, 1998, 20 (08) : 615 - 626
  • [34] DIETARY CARBOHYDRATES IN THE PREVENTION AND TREATMENT OF METABOLIC DISEASES - REPLY
    SZOSTAK, WB
    CYBULSKA, B
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1988, 47 (01): : 164 - 164
  • [35] Metabolic reprogramming by class I and II histone deacetylases
    Mihaylova, Maria M.
    Shaw, Reuben J.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2013, 24 (01): : 48 - 57
  • [36] Posttranslational modifications of histone deacetylases: Implications for cardiovascular diseases
    Eom, Gwang Hyeon
    Kook, Hyun
    PHARMACOLOGY & THERAPEUTICS, 2014, 143 (02) : 168 - 180
  • [37] HISTONE DEACETYLASES AS TARGETS FOR THE TREATMENT OF HUMAN NEURODEGENERATIVE DISEASES
    D'Mello, Santosh R.
    DRUG NEWS & PERSPECTIVES, 2009, 22 (09) : 513 - 524
  • [38] The interplay between microRNAs and histone deacetylases in neurological diseases
    Bourassa, Megan W.
    Ratan, Rajiv R.
    NEUROCHEMISTRY INTERNATIONAL, 2014, 77 : 33 - 39
  • [39] The role of histone deacetylases in inflammatory respiratory diseases: an update
    Pan, Sicen
    Wang, Xiangdong
    Jiao, Jian
    Zhang, Luo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (10) : 1193 - 1203
  • [40] Targeting histone deacetylases for the treatment of cancer and inflammatory diseases
    Huang, Lili
    JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 209 (03) : 611 - 616